Barbara Withers

发表

Haematopoietic stem cell transplantation for severe autoimmune diseases in children: A review of current literature, registry activity and future directions on behalf of the autoimmune diseases and paediatric diseases working parties of the European Society for Blood and Marrow Transplantation

G. Lucchini, B. Sharrack, C. Hawkey, 2022, British journal of haematology.

Adoptive T Cell Immunotherapy for Treatment of Ganciclovir‐Resistant Cytomegalovirus Disease in a Renal Transplant Recipient

S. Fleming, K. Nicholls, J. Sasadeusz, 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Sustained immunotolerance in multiple sclerosis after stem cell transplant

J. Zaunders, I. Sutton, J. Moore, 2022, Annals of clinical and translational neurology.

CMV-specific immune reconstitution following allogeneic stem cell transplantation

E. Blyth, D. Gottlieb, L. Clancy, 2016, Virulence.

Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients

S. Avdic, B. Slobedman, A. Abendroth, 2019, Front. Microbiol..

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-specific T cells.

P. Shaw, A. Yong, E. Blyth, 2017, Blood advances.

Long-term control of recurrent or refractory viral infections after allogeneic HSCT with third-party virus-speci ﬁ c T cells

P. Shaw, A. Yong, E. Blyth, 2017 .

Diversification and expansion of the EBV-reactive cytotoxic T lymphocyte repertoire following autologous haematopoietic stem cell transplant for multiple sclerosis.

I. Sutton, J. Moore, M. Visweswaran, 2023, Clinical immunology.

Pathogen-Specific T Cells Beyond CMV, EBV and Adenovirus

E. Blyth, L. Clancy, G. Sutrave, 2019, Current Hematologic Malignancy Reports.

Prophylactic antigen‐specific T‐cells targeting seven viral and fungal pathogens after allogeneic haemopoietic stem cell transplant

F. Luciani, B. Gloss, H. McGuire, 2021, Clinical & translational immunology.

Successful treatment of CMV, EBV, and adenovirus tissue infection following HLA‐mismatched allogeneic stem cell transplant using infusion of third‐party T cells from multiple donors in addition to antivirals, rituximab, and surgery

S. Avdic, E. Blyth, D. Gottlieb, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Mass cytometry reveals immune signatures associated with cytomegalovirus (CMV) control in recipients of allogeneic haemopoietic stem cell transplant and CMV‐specific T cells

F. Luciani, E. Patrick, B. Fazekas de St. Groth, 2020, Clinical & translational immunology.

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis

K. Muthiah, P. Macdonald, C. Hayward, 2022, Internal medicine journal.

Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry‐based proteomics in an Australian cohort

P. Macdonald, C. Hayward, A. Dogan, 2020, Internal medicine journal.

Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations

J. D. de Vries-Bouwstra, B. Sharrack, M. Labopin, 2021, Bone Marrow Transplantation.

Whole-Genome Approach to Assessing Human Cytomegalovirus Dynamics in Transplant Patients Undergoing Antiviral Therapy

A. Dhingra, T. Schulz, S. Linnenweber-Held, 2020, Frontiers in Cellular and Infection Microbiology.

Ultra-Sensitive Droplet Digital PCR for the Assessment of Microchimerism in Cellular Therapies.

Joey Lai, E. Blyth, D. Gottlieb, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pregnancy post autologous stem cell transplant with BEAM conditioning for multiple sclerosis

D. Ma, I. Sutton, J. Moore, 2021, Multiple sclerosis.

Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.

H. Atkins, J. Lechner-Scott, M. Onofrj, 2023, JAMA neurology.

Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program.

E. Blyth, D. Gottlieb, K. Micklethwaite, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Haematopoietic Stem Cell Transplantation Results in Extensive Remodelling of the Clonal T Cell Repertoire in Multiple Sclerosis

F. Luciani, R. Cheynier, J. Zaunders, 2022, Frontiers in Immunology.

Long-Term Suppression of Circulating Proinflammatory Cytokines in Multiple Sclerosis Patients Following Autologous Haematopoietic Stem Cell Transplantation

David D. F. Ma, I. Sutton, J. Moore, 2022, Frontiers in Immunology.

Detailed immunophenotyping of the hematopoietic graft from patients with multiple sclerosis undergoing autologous hematopoietic stem cell transplant.

M. Visweswaran, Melissa L. M. Khoo, J. Massey, 2023, Cytotherapy.

I. Kerridge, D. Ma, W. Stevenson, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

GE-148 (18F) injection PET/CT imaging and multiparametric MRI for detection of localized prostate cancer using customized MRI-based specimen molds

P. Choyke, M. Merino, B. Turkbey, 2011 .

Rates of Menstrual History-Taking and Counseling With Anticancer Treatments Are Low: People Who Menstruate Deserve Gender-Specific Cancer Care.

A. Anazodo, Verity L Chadwick, R. Dear, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.